LUCINAE Registry: Thoracic Cancers During Pregnancy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorOncology Institute of Southern Switzerland
About this trial
The LUCINAE Registry is an international, multicenter observational study collecting data on patients with thoracic cancers (including lung cancer) who are expecting a child. This includes women diagnosed during pregnancy, women who become pregnant during or after cancer, and men receiving cancer treatment at the time their partner conceives.
Because thoracic cancers during pregnancy are rare, there is limited information to guide clinical decisions. This registry aims to describe patient characteristics, diagnostic approaches, treatments, and maternal and fetal outcomes. Data are collected retrospectively and prospectively from participating centers.
The results of this registry are expected to improve understanding of thoracic cancers in this setting and support the development of future clinical recommendations.
Eligibility criteria
Qualifiers
Patients receiving a diagnosis of thoracic cancer during pregnancy
Patients who became pregnant while having active thoracic cancer
Patients previously treated for a thoracic cancer and becoming pregnant in the 5 years following end of treatment OR Men with a diagnosis of thoracic cancer (including lung cancer, mesothelioma, thymic epithelial tumors, neuroendocrine tumors or sarcoma of the thorax and other rare thoracic entities), who were undergoing active oncological treatment at the time their partner conceived their child.
2. Available information about pregnancy outcomes
Disqualifiers
1. Patient missing data about thoracic cancer stage and diagnosis
2. For retrospective patients, documented refusal to the use of clinical data for research purposes
Trial design
Treatments tested in this trial
- Not listed
Trial groups
100 Participants
are grouped into 2 trial groupsSponsors and collaborators
Oncology Institute of Southern Switzerland
Lead sponsor
Clinical Trial Unit Ente Ospedaliero Cantonale
Collaborator
Source ClinicalTrials.gov